PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
-8.18%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.06B
AUM Growth
-$181M
(-15%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
88.26%
Holding
30
New
–
Increased
4
Reduced
4
Closed
1
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
+$3.86M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
+$3.01M |
| 3 |
Gossamer Bio
GOSS
|
+$2.55M |
| 4 |
NovoCure
NVCR
|
+$1.33M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
+$11.7M |
| 2 |
Align Technology
ALGN
|
+$5.77M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
+$2.03M |
| 4 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
+$1.3M |
| 5 |
Vanda Pharmaceuticals
VNDA
|
+$195K |
Sector Composition
| 1 | Healthcare | 98.08% |
| 2 | Financials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aldeyra Therapeutics
ALDX
$328M
| $1.07M | 0.1% |
160,800
| – | – |
|
27
Kezar Life Sciences
KZR
$29.3M
| $781K | 0.07% |
65,620
| – | – |
|
28
Tactile Systems Technology
TCMD
$303M
| $381K | 0.04% |
27,100
| – | – |
|
29
UroGen Pharma
URGN
$874M
| $343K | 0.03% |
24,500
| – | – |
|
|
GRTS
30
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-666,127
| Closed | -$1.3M |
|